000 01720 a2200493 4500
005 20250512022920.0
264 0 _c19851218
008 198512s 0 0 eng d
022 _a0002-8614
024 7 _a10.1111/j.1532-5415.1985.tb04185.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMohs, R C
245 0 0 _aClinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies.
_h[electronic resource]
260 _bJournal of the American Geriatrics Society
_cNov 1985
300 _a749-57 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAnalysis of Variance
650 0 4 _aClinical Trials as Topic
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHydrocortisone
_xblood
650 0 4 _aInfusions, Parenteral
650 0 4 _aMale
650 0 4 _aMemory
_xdrug effects
650 0 4 _aMiddle Aged
650 0 4 _aNeuropsychological Tests
650 0 4 _aPhysostigmine
_xadministration & dosage
650 0 4 _aRadioimmunoassay
650 0 4 _aRandom Allocation
650 0 4 _aSomatostatin
_xblood
700 1 _aDavis, B M
700 1 _aGreenwald, B S
700 1 _aMathé, A A
700 1 _aJohns, C A
700 1 _aHorvath, T B
700 1 _aDavis, K L
773 0 _tJournal of the American Geriatrics Society
_gvol. 33
_gno. 11
_gp. 749-57
856 4 0 _uhttps://doi.org/10.1111/j.1532-5415.1985.tb04185.x
_zAvailable from publisher's website
999 _c2871128
_d2871128